Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $6.68-$15.42 |
Market Cap | $3.8B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $3B |
Revenue Growth (YoY) | 11.5% |
Gross Profit (12 Mos) | $1.1B |
Diluted EPS | $0.22 |
News
See moreYahoo Finance • 17 days ago
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
Yahoo Finance • 29 days ago
Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
Yahoo Finance • last month
Amneal Pharmaceuticals, Inc. (AMRX) Added to S&P SmallCap 600 Index, Boosting Investor Visibility
Yahoo Finance • 4 months ago
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 8,700 |
